MAPT and early-onset autosomal dominant Alzheimer disease: Wang et al. reported that miR-200a-3p, suppressed in Alzheimer’s disease models, when supplemented, led to reduced cell apoptosis, diminished amyloid beta-peptides deposits, and decreased tau phosphorylation (47).